Related Experiment Video
Updated: Jun 19, 2026
07:08
Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
Published on: February 2, 2024
Genome integrity: linking pluripotency and tumorgenicity
1Department of Cell Biology and Human Anatomy, Institute of Pediatric Regenerative Medicine, School of Medicine, University of California, Davis, 2425 Stockton Boulevard, Sacramento, CA 95817, USA. wbdeng@ucdavis.edu
Trends in Genetics : TIG
|October 6, 2009
Summary
Tumor suppressor p53 is vital for genome integrity and stem cell pluripotency. Overcoming p53 barriers could enhance induced pluripotent stem cell generation, but tumorgenicity must be assessed for safety.
Area of Science:
- Genomic stability and stem cell pluripotency research.
- Cancer biology and regenerative medicine.
Background:
- Genome integrity is crucial in cancer and stem cell biology.
- The tumor suppressor p53 links genome integrity, stem cell pluripotency, and reprogramming.
- p53 and other tumor suppressors may impede somatic cell reprogramming into induced pluripotent stem cells (iPSCs).
Purpose of the Study:
- To explore the dual role of p53 in genome integrity and stem cell pluripotency.
- To investigate the potential of overcoming tumor suppressor-mediated barriers to improve iPSC generation efficiency.
- To highlight the importance of assessing tumorgenicity in iPSC-derived cells for therapeutic applications.
Main Methods:
- Review of recent studies linking p53, genome integrity, and pluripotency.
- Analysis of the role of tumor suppressors as barriers in somatic cell reprogramming.
- Discussion on the necessity of evaluating tumorgenicity of iPSC-derived cells.
Main Results:
- p53 is essential for maintaining genome integrity and plays a critical role in stem cell pluripotency and reprogramming.
- Tumor suppressors, including p53, act as barriers that can hinder the efficient reprogramming of somatic cells into iPSCs.
- Efficient reprogramming may involve overcoming these natural cellular defenses.
Conclusions:
- The fundamental link between cancer and pluripotency is underscored by p53's dual function.
- Targeting tumor suppressor pathways could enhance iPSC generation efficiency.
- Thorough evaluation of tumorgenicity in iPSC-derived cells is paramount for safe therapeutic use.
Related Concept Videos
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:29Somatic to iPS Cell Reprogramming
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...
01:25Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...